HDAC9 and malignant colon neoplasm: Moreover, potent novel SFN and 6-SFN analogs that modified HAT and HDAC activities also attenuated HR/NHEJ repair mechanisms in colon cancer cells, providing a potential new avenue for chemosensitization [14].